Danh mục
Nạp tiền Tải xuống 0

Tất cả tài liệu

Sắp xếp:
  • Mới nhất
  • Xem nhiều nhất
  • Tải nhiều nhất

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

3 0 0
11 trang
Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis

Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis

9 0 0
12 trang
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: A real-world, patient-level analysis

Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: A real-world, patient-level analysis

12 0 0
8 trang
Đánh giá kết quả điều trị Erlotinib trong ung thư phổi không tế bào nhỏ di căn não có đột biến EGFR tại Bệnh viện Ung Bướu Hà Nội

Đánh giá kết quả điều trị Erlotinib trong ung thư phổi không tế bào nhỏ di căn não có đột biến EGFR tại Bệnh viện Ung Bướu Hà Nội

11 0 0
9 trang
Epidermal growth factor receptor mutations in non-small cell lung cancer patients from a single institution in Vietnam

Epidermal growth factor receptor mutations in non-small cell lung cancer patients from a single institution in Vietnam

8 0 0
7 trang
Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: A multicenter, retrospective real-world study

Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: A multicenter, retrospective real-world study

4 0 0
8 trang
Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer

Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer

3 0 0
13 trang
Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

2 0 0
14 trang
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: A prospective, single-arm, two-stage study

Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: A prospective, single-arm, two-stage study

8 0 0
10 trang
Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection

Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection

7 0 0
9 trang
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

13 0 0
20 trang
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)

Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: A prospective and single arm study (DANCE study)

6 0 0
6 trang
Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis

17 0 0
12 trang
Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients

Construction and validation of a two-gene signature based on SUMOylation regulatory genes in non-small cell lung cancer patients

13 0 0
12 trang
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

8 0 0
8 trang
A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: Rationale and study protocol design for the LOGIK1702 study

A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: Rationale and study protocol design for the LOGIK1702 study

6 0 0
6 trang
Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer

Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer

10 0 0
9 trang
Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

6 0 0
8 trang